2021 Brazilian Thoracic Association Recommendations for the Management of Severe Asthma

Advances in the understanding that severe asthma is a complex and heterogeneous disease and in the knowledge of the pathophysiology of asthma, with the identification of different phenotypes and endotypes, have allowed new approaches for the diagnosis and characterization of the disease and have resulted in relevant changes in pharmacological management. In this context, the definition of severe asthma has been established, being differentiated from difficult-to-control asthma. These recommendations address this topic and review advances in phenotyping, use of biomarkers, and new treatments for severe asthma. Emphasis is given to topics regarding personalized management of the patient and selection of biologicals, as well as the importance of evaluating the response to treatment. These recommendations apply to adults and children with severe asthma and are targeted at physicians involved in asthma treatment. A panel of 17 Brazilian pulmonologists was invited to review recent evidence on the diagnosis and management of severe asthma, adapting it to the Brazilian reality. Each of the experts was responsible for reviewing a topic or question relevant to the topic. In a second phase, four experts discussed and structured the texts produced, and, in the last phase, all experts reviewed and approved the present manuscript and its recommendations.

Citing Articles

Cardoso A, Ferreira A, Rabahi M J Bras Pneumol. 2025; 50(6):e20240296.

PMID: 39841777 PMC: 11796392. DOI: 10.36416/1806-3756/e20240296.

Brazilian Guideline for Exercise Testing in Children and Adolescents - 2024.

Carvalho T, Freitas O, Chalela W, Hossri C, Milani M, Buglia S Arq Bras Cardiol. 2024; 121(8):e20240525.

PMID: 39292116 PMC: 11495813. DOI: 10.36660/abc.20240525.

Diagnosis and treatment of asthma in childhood: an overview of guidelines.

Furukawa L, Garcia L, Pieta M, Castro M, Pinto L, Pitrez P J Bras Pneumol. 2024; 50(1):e20240051.

PMID: 38536970 PMC: 11095921. DOI: 10.36416/1806-3756/e20240051.

The role of IL10 and IL17 gene polymorphisms in treatment response in children and adolescents with severe asthma.

Vieira M, Queiroz M, de Santana M, Silva H, Oliveira A, Figueiredo C J Bras Pneumol. 2024; 49(6):e20230092.

PMID: 38232251 PMC: 10769478. DOI: 10.36416/1806-3756/e20230092.

Identifying the Characteristics of Responders and Nonresponders in a Behavioral Intervention to Increase Physical Activity Among Patients With Moderate to Severe Asthma: Protocol for a Prospective Pragmatic Study.

Lima F, Lunardi A, Pinheiro D, Carvalho-Pinto R, Stelmach R, Giavina-Bianchi P JMIR Res Protoc. 2023; 12:e49032.

PMID: 37651174 PMC: 10502597. DOI: 10.2196/49032.

References

Anenberg S, Henze D, Tinney V, Kinney P, Raich W, Fann N . Estimates of the Global Burden of Ambient , Ozone, and on Asthma Incidence and Emergency Room Visits. Environ Health Perspect. 2018; 126(10):107004. PMC: 6371661. DOI: 10.1289/EHP3766. View

Price D, Bosnic-Anticevich S, Pavord I, Roche N, Halpin D, Bjermer L . Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations. Clin Transl Allergy. 2019; 9:41. PMC: 6702739. DOI: 10.1186/s13601-019-0282-7. View

Tay T, Lee J, Radhakrishna N, Hore-Lacy F, Stirling R, Hoy R . A Structured Approach to Specialist-referred Difficult Asthma Patients Improves Control of Comorbidities and Enhances Asthma Outcomes. J Allergy Clin Immunol Pract. 2017; 5(4):956-964.e3. DOI: 10.1016/j.jaip.2016.12.030. View

Boulet L, Vervloet D, Magar Y, Foster J . Adherence: the goal to control asthma. Clin Chest Med. 2012; 33(3):405-17. DOI: 10.1016/j.ccm.2012.06.002. View

Heffler E, Carpagnano G, Favero E, Guida G, Maniscalco M, Motta A . Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC). Multidiscip Respir Med. 2020; 15(1):36. PMC: 7137762. DOI: 10.4081/mrm.2020.36. View

Gupta A, Ikeda M, Geng B, Azmi J, Price R, Bradford E . Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype. J Allergy Clin Immunol. 2019; 144(5):1336-1342.e7. DOI: 10.1016/j.jaci.2019.08.005. View

Gibson P, Henry R, Coughlan J . Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev. 2003; (2):CD001496. DOI: 10.1002/14651858.CD001496. View

Smith D, Minthorn E, Beerahee M . Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody. Clin Pharmacokinet. 2011; 50(4):215-27. DOI: 10.2165/11584340-000000000-00000. View

Mancuso C, Sayles W, Robbins L, Phillips E, Ravenell K, Duffy C . Barriers and facilitators to healthy physical activity in asthma patients. J Asthma. 2006; 43(2):137-43. DOI: 10.1080/02770900500498584. View

10.

Robinson D, Campbell D, Durham S, Pfeffer J, Barnes P, Chung K . Systematic assessment of difficult-to-treat asthma. Eur Respir J. 2003; 22(3):478-83. DOI: 10.1183/09031936.03.00017003. View

11.

Perkins P, Morris M . Vocal cord dysfunction induced by methacholine challenge testing. Chest. 2002; 122(6):1988-93. DOI: 10.1378/chest.122.6.1988. View

12.

Costello R, Cushen B . Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma. Eur Respir J. 2020; 55(5). DOI: 10.1183/13993003.00954-2020. View

13.

Moore W, Bleecker E, Curran-Everett D, Erzurum S, Ameredes B, Bacharier L . Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol. 2007; 119(2):405-13. PMC: 2837934. DOI: 10.1016/j.jaci.2006.11.639. View

14.

Head K, Chong L, Piromchai P, Hopkins C, Philpott C, Schilder A . Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4:CD011994. PMC: 8763400. DOI: 10.1002/14651858.CD011994.pub2. View

15.

Weinmayr G, Weiland S, Bjorksten B, Brunekreef B, Buchele G, Cookson W . Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med. 2007; 176(6):565-74. DOI: 10.1164/rccm.200607-994OC. View

16.

Coates A, Wanger J, Cockcroft D, Culver B, Diamant Z, Gauvreau G . ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017; 49(5). DOI: 10.1183/13993003.01526-2016. View

17.

Price D, Roman-Rodriguez M, McQueen R, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K . Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes. J Allergy Clin Immunol Pract. 2017; 5(4):1071-1081.e9. DOI: 10.1016/j.jaip.2017.01.004. View

18.

Cox G, Thomson N, Rubin A, Niven R, Corris P, Siersted H . Asthma control during the year after bronchial thermoplasty. N Engl J Med. 2007; 356(13):1327-37. DOI: 10.1056/NEJMoa064707. View

19.

Postma D, Brightling C, Baldi S, van den Berge M, Fabbri L, Gagnatelli A . Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med. 2019; 7(5):402-416. DOI: 10.1016/S2213-2600(19)30049-9. View

20.

Jares E, Baena-Cagnani C, Gomez R . Diagnosis of occupational asthma: an update. Curr Allergy Asthma Rep. 2012; 12(3):221-31. DOI: 10.1007/s11882-012-0259-2. View